Sciences of Pharmacy (SciPhar) is an international, peer-reviewed open-access journal of pharmacy. We offer a platform and place for researchers and intellectuals, especially the youth, to share their insights and works. SciPhar accepts original article, reviews, mini-review, book-review, technical note, case report, case series, clinical trial, opinion/perspective, conference proceeding, and pictorial essay. Author may submit or suggest another type of scientific manuscript.
Publication on SciPhar is free of charge at any stage. After acceptance, all papers are instantly templated and published online, with an average editorial process time of 1-7 days. Sciphar has 4 issues in each year.
[The reasons for prompt rejection of certain review articles can be found in the author instructions. Please familiarize yourself with the guidelines before submitting]
Contact us at our official email: sciphar@etflin.com
Our esteemed editorial board comprises 34 experts from 13 different countries. Our board members bring a diverse range of knowledge, skills, and experiences to the table, enabling us to provide a broad perspective on various issues.
Scopus ID Google Scholar ResearchGate
ORCID Google Scholar Scopus ID Research Gate
Google Scholar ResearchGate Scopus ID ORCID
Google Scholar ResearchGate Scopus ID ORCID
Google Scholar ResearchGate Scopus ID ORCID
ResearchGate Google Scholar ORCID Scopus ID
ORCID Scopus ID ResearchGate Google Scholar
Google Scholar ResearchGate Scopus ID ORCID
Google Scholar ResearchGate Scopus ID ORCID
Google Scholar ResearchGate Scopus ID ORCID
Google Scholar ResearchGate Scopus ID ORCID
Expertise: Telemedicine; Ocular therapy; Stem cell therapy; Regenerative medicine for ocular diseases
Google Scholar ResearchGate ORCID
Angi Nadya Bestari, S.Farm., M.Sc., Apt.
Department of Pharmaceutics, Faculty of Pharmacy, Gadjah Mada University, Yogyakarta 55281, Indonesia
Google Scholar
Keerthic Aswin, M.Pharm
CSIR-GATE JRF, Institute of Genomics and Integrative Biology, New Delhi, India
Google Scholar Scopus ID Research Gate
SOLYUR pharmaceutical company, Moscow 115432, Russia
Alert: We do not accept any paper generated by AI. A review paper should contain a discussion of previous works, criticism, comments, suggestions, and/or opinions of the experts (authors) supported by table(s) (previous work list and summary), figure(s) (chart, illustration, etc), and other data. Prompt rejection will be given if these criteria are not met.
"AI allowed, wisdom applied"
Submission and Tracking of manuscript
We use a submission system which can be accessed by registering an account through the Login button (top right).
SciPhar accepts original article, reviews, mini-review, book-review, technical note, case report, case series, clinical trial, opinion/perspective, conference proceeding, and pictorial essay. Author may submit or suggest another type of scientific manuscript.
Content, references, and others : 11 pt
Flexible font size
Abstract : 9 - 11 pt (depending on the number of abstract words)
Table and Figure : <11 pt (depending on the clarity, blurrines, and table or figure size)
Title must be clear and represent the whole manuscript content. The maximum title's length is 3 lines in the manuscript template. No abbreviations use unless the full term is included. We use 'Title Capitalization' rules for the paper title, check this good explanation and this APA style for title case rules.
Author name and affiliation
Put a number after the author name according to the affiliation number. If all authors are from the same affiliation, number after author's name is not necessary. Corresponding author should be marked with (*) after his/their name. Please provide all the corresponding emails if you have more than one corresponding author.
Please refrain from including any titles, degrees, or statuses in the authorship information. While we hold utmost respect for academic achievements, our goal is to promote equality in publishing, valuing the work of both young and senior researchers. These statuses could also change during the time.
ORCID logo should only be used if you have an ORCID account and make the logo linked to your ORCID link. You can also input your ORCID ID (not the full link, e.g. 0000-0000-0000-0000) in the authorship input during submission and we will add your ORCID to the final version of the published PDF.
Abstract
Unstructured abstract, not more than 250 words. The abstract should briefly highlight the background, methods, results, and conclusions of the study.
Provide 3-6 unique and diverse keywords. One keyword must not exceed three words and using abbreviations in keywords should be avoided. Choose keywords that highlight the crucial aspects of your work, excluding those already mentioned in the article title or extensively covered in the abstract. Keywords play a significant role in enhancing the visibility of your work in search engines. Therefore, using unique and distinct keywords from the title and abstract allows for a broader and more specific search scope for your work.
Figure must be clear and labelled. All figures must be included in the manuscript file and positioned as they are mentioned in the text for the first time. Please use bold to the figure number, for example: Figure 1. Flowchart of the methodology. Ensure that you place a period (.) at the end of each caption for figures and tables.
File type: JPG or PNG.
To ensure clarity of both the text and image in the figure, it is crucial to maintain the original aspect ratio when scaling up a figure. Stretching or widening the figure on only one side may cause blurriness and therefore, should be avoided.
Reproduction of figures
To reproduce a figure (already published in a paper in any journal) in SciPhar, copyright permission must be obtained. If a figure is reproduced without permission, it will be considered plagiarism and the authors will be asked to rectify the same. A note like 'copyright has been obtained from Einstein et al.' must be included within the Figure legend.
Tables must be created with the insert table feature of the Microsoft word. Please do not insert table as an image. All borders must be visible. The table header must be bold. Table number in caption must also be bold. Ensure that you place a period (.) at the end of each caption for figures and tables.
Example: Table 1. Patients’ characteristics.
In the event that a table extends beyond three pages, it is mandated to submit it as a supplemental table in EXCEL format or another datatable file. However, the supplemental table should still be mentioned in the text of the article to maintain its relevance and clarity.
Supplemental Data
To ensure accessibility and ease of use, supplemental data can be shared in the form of a file (ZIP or RAR) submitted with the manuscript or a permanent link to the data storage location. For supplemental data in the form of programs or applications, we recommend using GitHub. It is not acceptable to store the data on a personal cloud account like Gdrive or Onedrive.
Equations
Equations must be created with the insert equation feature of the Microsoft word. Please do not insert equation as an image. Each equation must be centered and labelled with a number.
Please use dots as a decimal marker, not commas.
Software to reduce grammatical errors
The use of grammarly is encouraged to minimize grammatical errors. Grammarly can be downloaded, installed, and added as an add-on to the Microsoft Word document.
Reference managing software
Authors are encouraged to use software such as Mendeley, Zotero, etc. to arrange the references. Mendeley and Zotero can be downloaded and installed. Once installed, they will appear on the 'References' tab on the Microsoft Word document.
We accept Vancouver style.
Authorship policy
In terms of planning the study design, data analysis, statistical analysis, software, executing work, writing, and editing, a significant contribution should be made by all contributing authors such as the first author, co-authors, and corresponding authors. Authors are encouraged to get familiar with the Committee on Publication Ethics (COPE) guidelines.
Corresponding author
The corresponding author will take the responsibility of communicating with the editors from the initial submission till publication. Depending on the requirement, there may be two corresponding authors. In the case of two corresponding authors, the asterisk '*' sign should accompany their names in the manuscript and the initials of the authors should accompany their email addresses in the manuscript.
Change of authorship
During the review process, the corresponding author may request that the authorship be changed, providing appropriate reasons for the request. It is not permitted to add or remove authors once a submission has been accepted.
Plagiarism
If possible, authors are requested to submit a plagiarism report from commercial software (or from a free online server) as a supplemental data. For all types of articles, the plagiarism percentage should be kept as low as possible (maximum upper limit 15% excluding references). Even if the plagiarism percentage remains below 15%, the authors may be further asked to reduce the plagiarism to increase the authenticity of the manuscript.
Animal ethics and cell lines
Studies should be carried out keeping in mind the standard guidelines set by OECD, CPCSEA, ICH, Animal Welfare Board of India, as well as other organizations. Ethical clearance with proper documents should be obtained from the concerned authority (for example, Institutional Animal Ethics Committee) to carry out the studies. Also, sufficient details regarding the document number should be mentioned in the manuscript.
Retraction
Retraction guidelines provided by the Committee on Publication Ethics (COPE) will be followed. A notice of retraction will be given to a paper if the findings are unreliable, unethical, plagiarized, or manipulated. To maintain integrity, the retracted paper will remain visible on the e-bulletin page. However, a notice of retraction will accompany the paper.
Dr Ratri Rokhani (Google Scholar)
Pharmacology Laboratory, Faculty of Pharmacy, Universitas Muhammadiyah Purwokerto, Banyumas 53182, Indonesia
Dr Irma Rahayu Latarissa (Google Scholar)
Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Bandung, Indonesia
Dr Shouvik Kumar Nandy (Google Scholar)
Assistant Professor in Pharmacology at Burdwan Institute of Pharmacy, Purba Barddhaman 713103, India
Dr apt. Adhe Septa Ryant Agus, M.Farm., AAAK. (Google Scholar)
STIKes Dirgahayu Samarinda
Dr Bikram Dutta Tassa (Google Scholar)
Associate Professor, Department of Pharmacology, Assam Medical College and Hospital, Dibrugarh.
Dr Mayang Kusuma Dewi (Google Scholar)
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia
Dr Bachtiar Rivai (Google Scholar)
Pharmaceutical Science and Technology, Chulalongkorn University, Bangkok, 10330, Thailand
Dr Yuniarti Falya (Google Scholar)
Sekolah Tinggi Farmasi Muhammadiyah Cirebon, Indonesia
Dr Mrinmoy Chakraborty (Google Scholar)
Department of Pharmaceutical Science, Kumaun University, Nainital 263002, India
Dr Maria Elvina Tresia Butar-Butar (Google Scholar)
Pharmacy Study Program, College of Health Sciences Dirgahayu, Samarinda 75122, Indonesia
Dr Ivan Ivanovich Krasnyuk (jr.) (Google Scholar)
PhD, Professor, Head of Department of Pharmaceutical Technology
A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University)
Dr Mayang Kusuma Dewi (Google Scholar)
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia
Dr Elizaveta Valeryevna Melnik (Google Scholar)
Department of Pharmaceutical and Toxicological Chemistry named after A.P. Arzamastsev, Sechenov University
Dr Faruk Jayanto Kelutur (Google Scholar)
Department of Pharmaceutical Science and Medicinal Chemistry, Faculty of Pharmacy, Sumedang, Universitas Padjadjaran, Indonesia
Dr Yuniarti Falya (Google Scholar)
Sekolah Tinggi Farmasi Muhammadiyah Cirebon
Dr apt. Erma Yunita, M.Sc. (Google Scholar)
Akademi Farmasi Indonesia, Yogyakarta, Indonesia
Prof Elena O. Bakhrushina (Google Scholar)
Department of Pharmaceutical Technology, A.P.Nelyubin Institute of Pharmacy and PHARMA-PREMIUM scientific educational center, Sechenov University.
Dr Bachtiar Rivai (Google Scholar)
Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand
Dr Sk Mizanul Haque (Google Scholar)
Department of Scientometrics, Library and Information Sciences, University of Calcutta, Kolkata, India
Dr Agus Rusdin (Google Scholar)
Department of Pharmacy, Bandung Health Polytechnic, West Java, Indonesia.
Dr Mayang Kusuma Dewi (Google Scholar)
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia
Dr Lalrinmawii (Google Scholar)
Medical Officer at Keitum Health & Wellness Centre under National Ayush Mission, Government of India
Dr Hardika Aditama (Google Scholar)
Department of Pharmaceutics, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia
Dr Ridho Islamie (Google Scholar)
Departemen Farmasi Klinis dan Komunitas, Fakultas Farmasi, Universitas Surabaya, Surabaya 60293, Indonesia
Dr James H. Zothantluanga (Google Scholar)
Dibrugarh University
Dr Iksen (Google Scholar)
Departemen Farmasi,
Sekolah Tinggi Ilmu Kesehatan Senior Medan,
Dr Mia Nisrina Ambar Fatin (Google Scholar)
Fakultas Farmasi, Universitas Bhakti Kencana, Bandung, Indonesia
Dr Muhammad Fauzi (Google Scholar)
Departement of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia
Dr Amelia Soyata (Google Scholar)
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor 45363, Indonesia
Dr Reza Pratama (Google Scholar)
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Bhakti Kencana, Cibiru 40614 Indonesia
Dr Novaliana Devianti Sagita (Google Scholar)
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Bhakti Kencana, Cibiru 40614 Indonesia
Any enquiry related to the journal, please reach us through email below.
Sciences of Pharmacy editorial's email: sciphar@etflin.com
Office: Sungai Manonda Street, Duyu, Tatanga,
Palu City 94225, Indonesia.
WhatsApp: +62 82216335184
Publisher email: halo@etflin.com
After submission of a manuscript, one of the editorial members will examine the quality of the manuscript. If the manuscript falls within the journal scope and showed high quality content, the editor will assign a minimum of two reviewers for the manuscript. After peer-review, the editor will make a decision based on the reviewer comments and recommendation. The decision made by the editor will be final. The journal follows a double-blind peer-review wherein the information of reviewers and authors are blinded from each other during the entire peer-review process. Please take a look at the Manuscript Lifecycle for detailed information.
All papers published in the journal are freely accessible immediately after publication. The papers are freely available to read, shared, and reproduced in any form with proper citation to the original work. Open access is a property of individual works and community standards that will enforce proper attribution and responsible use of the published work.
Publishing a paper in the journal is free. The journal do not take submission fees, editorial processing charges, article processing charges, page charges, or color charges.
The journal is licensed under the Creative Commons Attribution (CC BY) 4.0 International License. Detailed Licences Policy
The authors retain the copyright © of their published works. However, the published work of the
authors can be read, downloaded, shared, and cited with proper reference to the original work.
You may read this article for a better Understanding of Copyright.
Plagiarism is not tolerated in ETFLIN journals. Plagiarism is defined as the act of copying words, ideas, images, or data from another source, including your own publications, without crediting the original source. Text copied from another source must be reused between quotation marks, and the original source must be cited. If the design of a study, or the style or language of the article, was inspired by past research, it must be fully cited.
The industry standard program Turnitin is used to check all ETFLIN submissions for plagiarism. The manuscript may be rejected if plagiarism is discovered during the peer review process. If plagiarism is discovered after publication, an inquiry will be conducted and appropriate action will be taken in accordance with our policy.
Research Article
by Hiteswar Saikia, Mustakim Ahmed, Anju L. Saikia, Daisy Phukan
Sciences of Pharmacy; Vol 2, Issue 3; 06 July 2023
https://doi.org/10.58920/sciphar02030042
Review
by Callista Andinie Mulyadi, Yahdiana Harahap, Hary Sakti Muliawan
Sciences of Pharmacy; Vol 2, Issue 3; 06 July 2023
https://doi.org/10.58920/sciphar02030055
Review
Chatbots in Pharmacy: A Boon or a Bane for Patient Care and Pharmacy Practice?
by Chusnul Nur Ramadhani
Sciences of Pharmacy; Vol 2, Issue 3; 03 July 2023
https://doi.org/10.58920/sciphar02030001
Research Article
by Mubarak Muhammad Dahiru, AbdulAzeez Mumsiri Abaka, Neksumi Musa
Sciences of Pharmacy; Vol 2, Issue 3; 05 June 2023
https://doi.org/10.58920/sciphar02030024
Review
Cold Atmospheric Plasma: A Noteworthy Approach in Medical Science
by Bedanta Bhattacharjee, Rajashri Bezbaruah, Damanbhalang Rynjah, Arzoo Newar, Sindhuja Sengupta, Padmanath Pegu, Nikita Dey, Shekhar Chandra Bora, Dhunusmita Barman
Sciences of Pharmacy; Vol 2, Issue 2; 11 May 2023
https://doi.org/10.58920/sciphar02020046
Mini Review
Quality By Design: Approach to Analytical Method Validation
by Mayang Kusuma Dewi et al.
Sciences of Pharmacy; Vol 1, Issue 1
Review
Method and Critical Aspect of Semisolid Mixing
by Meylani Sutoro et al.
Sciences of Pharmacy; Vol 1, Issue 1
Opinion/Perspective
Impact of Preparation Method in Co-Amorphous System
by Amelia Soyata et al.
Sciences of Pharmacy; Vol 1, Issue 1
Research Article
by Bikram Dutta Tassa et al.
Sciences of Pharmacy; Vol 2, Issue 1
Review
Thermal Behavior of Polymers in Solid-State
by Maria Elvina Tresia Butar-butar et al.
Sciences of Pharmacy; Vol 1, Issue 1
We Computerize Sciences, We Publish Sciences, We Are Scientist